Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Drug pricing

Value for money key in prescribing consultation, CCGs leader says

The webinar and two live meetings have been held to encourage participation in NHS England and NHS Clinical Commissioners’ national consultation entitled ‘Items which should not routinely be prescribed in primary care’.

applying anti fungal cream to treat athlete's foot

Source: shutterstock.com

Royal Pharmaceutical Society says proposed prescribing restriction of clinically effective medicines for common conditions such as head lice or athlete’s foot would fundamentally alter the principle that NHS care is free at the point of delivery

Value for money for the NHS is key to NHS England’s consultation on items that should not be routinely prescribed in primary care, the organisation representing clinical commissioning groups (CCGs) has told a webinar held as part of the consultation.

The webinar and two live meetings have been held to encourage participation in NHS England and NHS Clinical Commissioners’ national consultation ‘Items which should not routinely be prescribed in primary care’, which will close on 21 October 2017.

Speaking at the webinar on 10 October 2017, Julie Wood, chief executive of NHS Clinical Commissioners, provided an overview of the consultation and encouraged participants to put forward their views for consideration before the imminent deadline.

The consultation is seeking the views of the public, patients and professionals on proposed national guidance for CCGs on medicines which can be considered to be of low priority for NHS funding.

“It is important to get the greatest value from every NHS pound spent,” said Wood.

“Across England, there is significant variation on what is being prescribed, at what price and to whom.”

The consultation focuses on 18 specific products, including homeopathy and travel vaccinations, for which recommendations have been made on how they should be prescribed in primary care.

These include advice that the product should not be routinely prescribed but may be prescribed in certain circumstances; that CCGs should actively ‘deprescribe’ in all patients where appropriate; or that the product should be prescribed by specialist services.

A second part of the review is to seek views on the prescribing future of more than 3,200 products that cost the NHS over £645m per year and can be bought over the counter.

These products can sometimes be bought over the counter for less than the NHS would pay; are used to treat a self-limiting condition that can heal or be cured of its own accord; and are used to treat a condition that lends itself to self-care.

Examples of some of these over-the-counter medicines include antifungal creams, sunscreens and laxatives.

The Royal Pharmaceutical Society, which is on the working group for the consultation, has expressed concerns about the proposed restriction of prescribing clinically effective medicines to treat common conditions such as head lice or athlete’s foot, saying it believed this move would fundamentally alter the principle that NHS care is free at the point of delivery.

Following closure of the consultation on 21 October 2017, NHS England will feedback to CCGs, a summary of the responses received, allowing an opportunity for reflection and review. Then NHS England and NHS Clinical Commissioners will finalise the clinical commissioning guidance, which is expected to be sent out to CCGs in November 2017.

Individual CCGs can then decide whether to implement the national clinical commissioning guidance.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203733

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • applying anti fungal cream to treat athlete's foot

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.